PC
ONCE

Polar Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Polar Capital’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-15,000
Closed -$896K – 260
2017
Q2 		$896K Buy
+15,000
New +$838K 0.01% 230

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Polar Capital's ONCE Position: Q3 2017 in Review

Polar Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2017, closing a stake of 15,000 shares — an estimated $896K sold.

Polar Capital first reported a position in ONCE in Q2 2017 and held it in 1 quarter. The position peaked at $896K in Q2 2017. 163 funds tracked by Wall St. Rank hold ONCE as of Q3 2017.

  • Polar Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Polar Capital sold 15,000 Spark Therapeutics, Inc. Common Stock shares in Q3 2017, an estimated $896K.
  • Polar Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Polar Capital's Spark Therapeutics, Inc. Common Stock position peaked at $896K in Q2 2017.
  • 163 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2017.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.